Article and Video CATEGORIES
RADIANT and SELECT: Is Adjuvant Erlotinib Effective in Early-Stage Lung Cancer?
Drs. Nasser Hanna and Melissa Johnson discuss new trial evidence for the use of adjuvant Erlotinib for early-stage lung cancer.
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
Article
Da click aquí para más información y para registrarte ahora
Forum Discussions
Hi Ascardino, Welcome to Grace. I'm so sorry to hear of your situation. While we don't have specific info or expertise on ovarian cancer, I did some searching for information. It...
Recent Comments
Hi Hopish hope, Welcome to…
By JanineT GRACE … on
colon cancer and HIV
By Hopish hope on
I don't know what to do. No insurance